Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 226 to 250 of 2529

TitleReference numberPublishedLast updated
Vibegron for treating symptoms of overactive bladder syndromeTA999
Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced oesophageal and gastro-oesophageal junction cancerTA737
Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinomaTA997
Adrenal insufficiency: identification and managementNG243
Risankizumab for treating moderately to severely active ulcerative colitisTA998
Phrenic nerve pacing for congenital central hypoventilation syndromeHTG725
Caval valve implantation for tricuspid regurgitationHTG726
Phrenic nerve pacing for ventilator-dependent high cervical spinal cord injuryHTG727
Relugolix for treating hormone-sensitive prostate cancerTA995
Linzagolix for treating moderate to severe symptoms of uterine fibroidsTA996
Diabetic retinopathy: management and monitoringNG242
Enzalutamide for treating non-metastatic prostate cancer after radical prostatectomy or radiotherapy (terminated appraisal)TA994
Abaloparatide for treating osteoporosis after menopauseTA991
Burosumab for treating X-linked hypophosphataemia in adultsTA993
CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attackHTG724
AnaphylaxisQS119
Trastuzumab deruxtecan for treating HER2-low metastatic or unresectable breast cancer after chemotherapyTA992
Ivacaftor–tezacaftor–elexacaftor, tezacaftor–ivacaftor and lumacaftor–ivacaftor for treating cystic fibrosisTA988
Etranacogene dezaparvovec for treating moderately severe or severe haemophilia BTA989
Tenecteplase for treating acute ischaemic strokeTA990
Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (terminated appraisal)TA987
Lebrikizumab for treating moderate to severe atopic dermatitis in people 12 years and overTA986
Selective internal radiation therapies for treating hepatocellular carcinomaTA688
Minimally invasive percutaneous surgical techniques with internal fixation for correcting hallux valgusHTG723
Tafamidis for treating transthyretin amyloidosis with cardiomyopathyTA984

Results per page

  1. 10
  2. 25
  3. 50
  4. All